These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 11277694

  • 1. Membrane-associated respiratory syncytial virus F protein expressed from a human rhinovirus type 14 vector is immunogenic.
    Dollenmaier G, Mosier SM, Scholle F, Sharma N, McKnight KL, Lemon SM.
    Virology; 2001 Mar 15; 281(2):216-30. PubMed ID: 11277694
    [Abstract] [Full Text] [Related]

  • 2. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
    Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T.
    Biochem Biophys Res Commun; 2009 Apr 17; 381(4):528-32. PubMed ID: 19233131
    [Abstract] [Full Text] [Related]

  • 3. Alphavirus replicon particles encoding the fusion or attachment glycoproteins of respiratory syncytial virus elicit protective immune responses in BALB/c mice and functional serum antibodies in rhesus macaques.
    Elliott MB, Chen T, Terio NB, Chong SY, Abdullah R, Luckay A, Egan MA, Boutilier LA, Melville K, Lerch RA, Long D, Eldridge JH, Parks CL, Udem SA, Hancock GE.
    Vaccine; 2007 Oct 10; 25(41):7132-44. PubMed ID: 17850933
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.
    Ternette N, Tippler B, Uberla K, Grunwald T.
    Vaccine; 2007 Oct 10; 25(41):7271-9. PubMed ID: 17825960
    [Abstract] [Full Text] [Related]

  • 5. Pulmonary delivery of respiratory syncytial virus DNA vaccines using macroaggregated albumin particles.
    Harcourt JL, Anderson LJ, Sullender W, Tripp RA.
    Vaccine; 2004 Jun 02; 22(17-18):2248-60. PubMed ID: 15149784
    [Abstract] [Full Text] [Related]

  • 6. Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells.
    Nallet S, Amacker M, Westerfeld N, Baldi L, König I, Hacker DL, Zaborosch C, Zurbriggen R, Wurm FM.
    Vaccine; 2009 Oct 30; 27(46):6415-9. PubMed ID: 19559121
    [Abstract] [Full Text] [Related]

  • 7. [Plasmid construction, expression, immunogenicity and protective efficacy of recombinant protein candidate vaccine of respiratory syncytial virus].
    Zeng RH, Gong W, Fang XP, Zhang ZY, Mei XG.
    Sheng Wu Gong Cheng Xue Bao; 2005 Jul 30; 21(4):534-9. PubMed ID: 16176088
    [Abstract] [Full Text] [Related]

  • 8. Intranasal proteosome-based respiratory syncytial virus (RSV) vaccines protect BALB/c mice against challenge without eosinophilia or enhanced pathology.
    Cyr SL, Jones T, Stoica-Popescu I, Brewer A, Chabot S, Lussier M, Burt D, Ward BJ.
    Vaccine; 2007 Jul 20; 25(29):5378-89. PubMed ID: 17561317
    [Abstract] [Full Text] [Related]

  • 9. Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.
    Kim S, Jang JE, Yu JR, Chang J.
    Vaccine; 2010 May 14; 28(22):3801-8. PubMed ID: 20362203
    [Abstract] [Full Text] [Related]

  • 10. Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies.
    Voges B, Vallbracht S, Zimmer G, Bossow S, Neubert WJ, Richter K, Hobeika E, Herrler G, Ehl S.
    Cell Immunol; 2007 Jun 14; 247(2):85-94. PubMed ID: 17904538
    [Abstract] [Full Text] [Related]

  • 11. Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
    Bian C, Liu S, Liu N, Zhang G, Xing L, Song Y, Duan Y, Gu H, Zhou Y, Zhang P, Li Z, Zhang K, Wang Z, Zhang S, Wang X, Yang P.
    Antiviral Res; 2014 Apr 14; 104():110-7. PubMed ID: 24509239
    [Abstract] [Full Text] [Related]

  • 12. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X, Liang B, Ngwuta J, Liu X, Surman S, Lingemann M, Kwong PD, Graham BS, Collins PL, Munir S.
    J Virol; 2017 Nov 15; 91(22):. PubMed ID: 28835504
    [Abstract] [Full Text] [Related]

  • 13. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine.
    Huang Y, Cyr SL, Burt DS, Anderson R.
    J Clin Virol; 2009 Apr 15; 44(4):287-91. PubMed ID: 19233722
    [Abstract] [Full Text] [Related]

  • 14. Non-propagating, recombinant vesicular stomatitis virus vectors encoding respiratory syncytial virus proteins generate potent humoral and cellular immunity against RSV and are protective in mice.
    Johnson JE, McNeil LK, Megati S, Witko SE, Roopchand VS, Obregon JH, Illenberger DM, Kotash CS, Nowak RM, Braunstein E, Yurgelonis I, Jansen KU, Kalyan NK, Sidhu MK.
    Immunol Lett; 2013 Feb 15; 150(1-2):134-44. PubMed ID: 23261719
    [Abstract] [Full Text] [Related]

  • 15. Respiratory syncytial virus: reverse genetics and vaccine strategies.
    Collins PL, Murphy BR.
    Virology; 2002 May 10; 296(2):204-11. PubMed ID: 12069519
    [No Abstract] [Full Text] [Related]

  • 16. Nonreplicating vaccines can protect african green monkeys from the memphis 37 strain of respiratory syncytial virus.
    Eyles JE, Johnson JE, Megati S, Roopchand V, Cockle PJ, Weeratna R, Makinen S, Brown TP, Lang S, Witko SE, Kotash CS, Li J, West K, Maldonado O, Falconer DJ, Lees C, Smith GJ, White P, Wright P, Loudon PT, Merson JR, Jansen KU, Sidhu MK.
    J Infect Dis; 2013 Jul 15; 208(2):319-29. PubMed ID: 23596321
    [Abstract] [Full Text] [Related]

  • 17. Chimeric subgroup A respiratory syncytial virus with the glycoproteins substituted by those of subgroup B and RSV without the M2-2 gene are attenuated in African green monkeys.
    Cheng X, Zhou H, Tang RS, Munoz MG, Jin H.
    Virology; 2001 Apr 25; 283(1):59-68. PubMed ID: 11312662
    [Abstract] [Full Text] [Related]

  • 18. Long-lasting balanced immunity and protective efficacy against respiratory syncytial virus in mice induced by a recombinant protein G1F/M2.
    Zeng R, Qi X, Gong W, Mei X, Wei L, Ma C, Yin X.
    Vaccine; 2007 Oct 16; 25(42):7422-8. PubMed ID: 17850930
    [Abstract] [Full Text] [Related]

  • 19. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
    Brock LG, Liu X, Liang B, Lingemann M, Liu X, Herbert R, Hackenberg AD, Buchholz UJ, Collins PL, Munir S.
    J Virol; 2018 Sep 01; 92(17):. PubMed ID: 29925656
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.